| 1 |
26431276 | Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk. | 2015 Oct 20 |
7 |
| 2 |
25064746 | Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. | 2014 Dec |
2 |
| 3 |
22562379 | Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes. | 2012 Nov |
1 |
| 4 |
22869883 | Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation. | 2012 Sep 10 |
1 |
| 5 |
19029964 | Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study. | 2009 May |
1 |
| 6 |
19841190 | The proteasome inhibitor bortezomib enhances the susceptibility to viral infection. | 2009 Nov 15 |
2 |
| 7 |
18539902 | Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation. | 2008 Aug 15 |
2 |